{"query":"xzom.com","mode":"domain","best":{"domain":"xzom.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"Xzom Inc\\.","summary":"Our early disease detection platform is low\\-cost, easy\\-to\\-use, and leverages the power of biomarker\\-rich exosomes to transform outcomes for patients everywhere\\.","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://xzom.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-24T01:35:23.957Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["early disease detection","exosomes","biomarkers","diagnostics","patient care"],"audience":"mixed","agent_uses":[],"language":"en","platform_generated":false,"agent_summary":"Xzom Inc. develops a low-cost early disease detection platform using biomarker-rich exosomes. Site content is mostly placeholder text.","llms_txt_cached":"https://agentwebmap.com/v1/domain/xzom.com/llms.txt","agentic":"informational","section_keys":["news","optional","pages","team","team-member-groups"],"section_partial":false,"section_indexed_at":"2026-10-24T01:35:25.558Z","why":["authority 46 (listed)","checked 781 minutes ago"]},"read":{"llms_txt":"https://xzom.com/llms.txt","llms_full_txt":null,"nested_llms_txt":[]},"terms":null,"health":{"ok":true,"status":"valid","tier":"listed","authority":46,"last_checked":"2026-10-24T01:35:23.957Z","checked_minutes_ago":781,"stale":false,"max_age_seconds":86400,"live_checked":false,"http_status":200,"last_valid":"2026-10-24T01:35:23.957Z","content_hash":"d84725abe2af5498264ddae05b13140d","documentation_indexed_at":"2026-10-24T01:35:22.745Z"},"sources":[],"match":{"strength":"domain","reason":"Exact domain or its registered publisher."},"provenance":{"selection":"directory","reranked":false,"verification":"domain_ownership","terms":"unknown","excerpts":"publisher_link_metadata","health":"stored_crawl"},"alternatives":[]}